Highlights on this story:
- Medial EarlySign announced the first clinical implementation of its AI-based solution to identify patients at highest risk of COVID-19 complications, with leading Israeli HMO Maccabi Healthcare Services.
- The new algorithm uses a wide range of routine medical information to objectively flag high-risk patients who should be fast-tracked for COVID-19 testing, facilitating earlier treatment to reduce severe cases, optimize treatment decisions and help save lives.
Maccabi Healthcare Services, Israel’s leading HMO with 2.4 million members, announced today the deployment of a new AI-powered algorithm that identifies individuals estimated to be at the highest risk of severe COVID-19 complications due to pre-existing conditions and other health factors. The new algorithm has already identified the top 2% of highest-risk patients (approximately 40,000 people), following analysis of all Maccabi patients’ anonymized electronic health records (EHRs).
Source: Hit Consultant
